Measuring Exposure to Opioids Using Self‐Reported Medication Use Data Versus General Practitioner Prescription Records in the UK Biobank Study
Pharmacoepidemiology and Drug Safety · 2025
DOI: 10.1002/pds.70280 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2025. Verfasst von Allison Domingues und 7 weiteren Autor:innen. Beteiligte Einrichtung: Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France. Hauptthemen laut MEDLINE: Analgesics, Opioid, Self Report, General Practitioners, Drug Prescriptions. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Institut National Du Cancer, NIH HHS.
Abstract (Originalsprache)
Purpose
The ongoing global increase in opioid use necessitates studies examining long‐term health impacts. Prospective cohorts frequently rely on self‐reported medication use data which may be subject to several types of bias compared to more objective measurements. We evaluated the agreement between two opioid exposure measures in the UK Biobank (UKBB)—self‐reported regular use and prescription‐based indicators using linked general practitioner (GP) records.
Methods
Our analysis included 171 813 UKBB participants with linked prescription records. At baseline, participants reported medications taken regularly (weekly, monthly, every 3 months). We assessed agreement between self‐reported regular opioid use and opioid prescription records prior to enrollment across various look‐back periods and prescription counts. Logistic regressions assessed factors associated with omission and commission.
Results
Agreement was moderate to substantial between self‐reported opioid use and prescription records. The strongest agreement was observed for ≥ 3 prescriptions in the past 365 days (Cohen's Kappa = 0.66). Subgroup analysis showed better agreement for analgesic opioids (Kappa = 0.43–0.63) than for non‐analgesic opioids (Kappa = 0.25–0.34). Omission odds were highest with increasing months since the last record and lowest for individuals with chronic pain. Commission odds were highest for individuals with chronic pain and lowest in married/partnered individuals.
Conclusions
This analysis indicates that self‐reported regular opioid use in the UKBB could be a valid indicator for identifying individuals with repeated prescriptions for analgesic opioids in the past year, while also capturing opioid use from non‐linked sources. However, agreement was low for non‐analgesic opioids, suggesting limited utility of self‐report for capturing use of these medications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
- Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
- School of Pharmacy and Pharmaceutical Sciences, University of Queensland, Brisbane, Australia.
- National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, New South Wales, Australia.
- School of Population Health, University of New South Wales Sydney, Sydney, New South Wales, Australia.
- Medicines Intelligence Research Program, University of New South Wales Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Mahdi Sheikh
Förderung
- NCI NIH HHS
- Institut National Du Cancer
- NIH HHS
- Institut pour la Recherche en Santé Publique
- French National Cancer Institute
- World Health Organization
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Domingues, A., Zhai, Y., Parat, M. O., Viallon, V., Degenhardt, L., Pearson, S. A., Zhou, J., & Sheikh, M. (2025). Measuring Exposure to Opioids Using Self‐Reported Medication Use Data Versus General Practitioner Prescription Records in the UK Biobank Study. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70280
Vancouver
Domingues A, Zhai Y, Parat MO, Viallon V, Degenhardt L, Pearson SA, et al. Measuring Exposure to Opioids Using Self‐Reported Medication Use Data Versus General Practitioner Prescription Records in the UK Biobank Study. Pharmacoepidemiology and Drug Safety. 2025. doi:10.1002/pds.70280
BibTeX
@article{Domingues2025,
author = {Domingues, Allison and Zhai, Yue and Parat, Marie-Odile and Viallon, Vivian and Degenhardt, Louisa and Pearson, Sallie-Anne and Zhou, Jifang and Sheikh, Mahdi},
title = {Measuring Exposure to Opioids Using Self‐Reported Medication Use Data Versus General Practitioner Prescription Records in the UK Biobank Study},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2025},
doi = {10.1002/pds.70280}
}
EUVIMED